Fake Ozempic Is Surging
When Andy Morling heard about a revolutionary new weight-loss cure on the BBC last spring, he figured it might spark a shadier market for fakes.
His hunch was right. Almost a year later, the law-enforcement veteran who spent the last four decades helping to bring down drug gangs and child sexual abusers is leading the charge against criminals looking to profit from the very human desire to slim down.
Both organized crime and unscrupulous lone entrepreneurs are looking to capitalize on the weight-loss frenzy with concoctions that range from useless to potentially deadly. Their packaging mimics Novo Nordisk...
Source: TIME: Health - March 13, 2024 Category: Consumer Health News Authors: Ashleigh Furlong/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes
(MedPage Today) -- In a phase I trial, investigational amycretin led to greater weight loss compared with historical benchmarks set by semaglutide (Wegovy), according to drugmaker Novo Nordisk. (Forbes)
Use of the Omnipod 5 automated insulin delivery... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 12, 2024 Category: Endocrinology Source Type: news
Vitamin D Supplement Protects Insulin-Producing Cells in T1D Vitamin D Supplement Protects Insulin-Producing Cells in T1D
Vitamin D supplementation can preserve beta-cell function and extend the " honeymoon phase " or partial remission period in type 1 diabetes, a recent study suggested..Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Use of CGM Linked to Lower Risk of Retinopathy in Type 1 Diabetes
(MedPage Today) -- In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and proliferative diabetic retinopathy... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 9, 2024 Category: Cardiology Source Type: news
Home Insulin Pumps Safe for In-Hospital Pediatric Care Home Insulin Pumps Safe for In-Hospital Pediatric Care
Continued use of home insulin pumps offered better glucose control in pediatric nonintensive care unit admissions than subcutaneous injections, finds large pediatric study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 7, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
Tuesday, the FDA approved DexCom Inc’s DXCM Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin. William Blair…#fda #dexcomincs #cgm #williamblair #abbottlaboratories #dexcom #abbott #hsa #lingo #dxcm (Source: Reuters: Health)
Source: Reuters: Health - March 6, 2024 Category: Consumer Health News Source Type: news
High-Fiber Gut Microbe Makeover Aids Weight Loss High-Fiber Gut Microbe Makeover Aids Weight Loss
A fiber supplement of resistant starch achieved weight loss and insulin sensitivity in people with overweight or obesity, partially by changes in gut microbiota.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
FDA Approves First OTC Continuous Glucose Monitor FDA Approves First OTC Continuous Glucose Monitor
The Dexcom Stelo Glucose Biosensor System is for adults with or without diabetes who don ' t use insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
FDA signs off on first over-the-counter continuous glucose monitor
The U.S. Food and Drug Administration said Tuesday that the federal agency had approved an over-the-counter continuous glucose monitor for those who do not use insulin. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 5, 2024 Category: Consumer Health News Source Type: news
Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone
Orally dosed small molecule candidate is designed to reduce/eliminate need for injectable insulin Safety profile established in more than 700 patients While type 2 diabetes is frequently discussed in the media, the 1.3 million U.S. adults who struggle with type 1 diabetes are sometimes forgotten…#fda #tzield #proventionbio #sanofisa #biodexa #tolimidone #aydinhuseynov #mdcfa #ladenburgthalmann #pfizerpfi (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2024 Category: Consumer Health News Source Type: news
How Much Can Technology Ease Diabetes Distress? How Much Can Technology Ease Diabetes Distress?
Adults with type 1 diabetes experienced a high level of diabetes distress, a psychological burden improved in some by the hybrid closed-loop system for insulin delivery.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 1, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Your Inhalers and EpiPens Aren't Very Healthy for the Environment
For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that. (Source: NYT Health)
Source: NYT Health - February 26, 2024 Category: Consumer Health News Authors: Ted Alcorn Tags: Medical Devices Waste Materials and Disposal Drugs (Pharmaceuticals) Recycling of Waste Materials Insulin Greenhouse Gas Emissions Plastics Hypodermic Needles and Syringes your-feed-healthcare Source Type: news
Melatonin Improves Sleep Quality, but Not Insulin Resistance, for Night Shift Workers
MONDAY, Feb. 26, 2024 -- Melatonin treatment improves sleep quality but does not improve insulin resistance after 12 weeks of administration in rotating night shift (NS) workers, according to a study published in the January issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2024 Category: Pharmaceuticals Source Type: news
Your Inhalers and EpiPens Aren't Very Healthy for the Environment
For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that. (Source: NYT Health)
Source: NYT Health - February 26, 2024 Category: Consumer Health News Authors: Ted Alcorn Tags: Medical Devices Waste Materials and Disposal Drugs (Pharmaceuticals) Recycling of Waste Materials Insulin Greenhouse Gas Emissions Plastics Hypodermic Needles and Syringes your-feed-healthcare Source Type: news
Can You Recycle Medical Devices Like Insulin Pens, Inhalers and Covid Tests?
Inhalers, EpiPens, home tests for flu or Covid, mouth guards. They accumulate in our homes, and recycling methods and advice can be tricky to pin down. (Source: NYT Health)
Source: NYT Health - February 26, 2024 Category: Consumer Health News Authors: Ted Alcorn Tags: Recycling of Waste Materials Medical Devices Waste Materials and Disposal Drugs (Pharmaceuticals) Asthma Containers and Packaging Sustainable Living Greenhouse Gas Emissions Food and Drug Administration Environmental Conservation Departm Source Type: news
